MPM Capital
Venture Capital
World-leading biotechnology investment firm with 30+ years of experience building and investing in biotech companies seeking to deliver transformative therapies to patients.
Early Stage
Growth
Seed
Biotech
Life Sciences
Oncology
biotechnology
cell therapy
drug discovery
gene therapy
immunology
neuroscience
- Headquarters
- Boston, United States
- Founded
- 1997
- Website
- mpmbioimpact.com
- AUM
- $3.0B
- Total Investments
- 23
- Last Investment
- Nov 2020
- Geographic Focus
- United States
Investment Thesis
We invest in private and public companies across the drug development process with the goal of transforming scientific breakthroughs into life saving medicines.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account